Welcome to our dedicated page for James Hardie Industries plc news (Ticker: $JHX), a resource for investors and traders seeking the latest updates and insights on James Hardie Industries plc stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect James Hardie Industries plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of James Hardie Industries plc's position in the market.
James Hardie Industries (ASX: JHX; NYSE: JHX) announced record financial results for the fiscal year ending March 31, 2024. The company achieved net sales of US$3.9 billion, a 4% increase from the previous year, and adjusted net income of US$707.5 million, up 17%. In the fourth quarter, net sales reached US$1.004 billion, a 9% rise, with adjusted net income of US$174.2 million. The North America Fiber Cement segment saw a 13% increase in net sales, while the Asia Pacific segment reported a 5% rise. The Europe Building Products segment maintained flat net sales but saw a 53% increase in EBIT. James Hardie projects a strong performance for fiscal year 2025, with North American volumes expected to range between 2,950 million to 3,150 million standard feet, and an EBIT margin between 29% to 31%.